AbRefine: Framework-Conditioned Refinement for Structure-Guided Antibody CDR Design

Abstract

Structure-guided antibody CDR design constrains residue selection using backbone geometry, but structural evidence alone may leave multiple amino acids plausible. We investigate whether the fixed antibody framework provides complementary sequence information for resolving this ambiguity. We introduce AbRefine, an information-aware fusion framework that combines backboneconditioned structural predictions with framework-conditioned sequence distributions derived from a pretrained antibody language model with all designed CDRs masked. Its Information-Aware Fusion (IAF) module learns residue-specific fusion weights from the uncertainty, disagreement, and information content of the two predictive distributions, while keeping both pretrained experts frozen. Controlled interventions show that the signal is target specific: matched frameworks outperform shuffled frameworks by 7.37 percentage points, and the largest gain occurs at positions with high structural uncertainty and informative framework evidence (+5.77 points). Compared with static fusion, IAF further improves AbMPNN recovery by +1.53 points (95% CI +0.93 to +2.14) and significantly reduces native negative log-likelihood for both AbMPNN and AntiFold, without detectable degradation in fold-back structural compatibility. These results show that framework context provides information beyond backbone geometry and that learning its residue-specific utility enables effective adaptive fusion for antibody CDR design.